Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVA Mobilization in Relapsed/Refractory DLBCL
NCT01555541Phase 2Completed
- Start
- May 2012
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in diffuse large B-cell lymphoma (DLBCL). Started May 2012; status: completed.
02
Drugs
ofatumumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01555541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555541.